Communicating risk reductions. Modifying risk is different to treating illness

BMJ. 1999 Feb 27;318(7183):603-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Humans
  • Hypercholesterolemia / drug therapy*
  • Risk Factors

Substances

  • Anticholesteremic Agents